CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 135 enrolled
Drug / intervention
Implantation with the commercially available Axium Neurostimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02169401
NCT02169401N/ACompleted
CompareCT.gov

a PRospEctive Post Market Trial of Drg stImulation With the Commercially Available Axium

Abbott Medical Devices·observational·Posted Jun 23, 2014·Updated Nov 14, 2024

In Brief

An observational study evaluating Implantation with the commercially available Axium Neurostimulator for Chronic Pain. Completed, enrolled 135 participants across 1 site.

Detailed Summary

08-SMI-2012 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of intractable, chronic pain.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 23, 2014
Enrollment StartNov 1, 2012
Primary CompletionJan 25, 2017
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 12.0 years ago

Interventions

Implantation with the commercially available Axium Neurostimulatordevice